GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » COGS-to-Revenue

Siemens Healthineers AG (WBO:SHL) COGS-to-Revenue : 0.61 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG COGS-to-Revenue?

Siemens Healthineers AG's Cost of Goods Sold for the three months ended in Mar. 2025 was €3,586 Mil. Its Revenue for the three months ended in Mar. 2025 was €5,909 Mil.

Siemens Healthineers AG's COGS to Revenue for the three months ended in Mar. 2025 was 0.61.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Siemens Healthineers AG's Gross Margin % for the three months ended in Mar. 2025 was 39.31%.


Siemens Healthineers AG COGS-to-Revenue Historical Data

The historical data trend for Siemens Healthineers AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG COGS-to-Revenue Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.61 0.63 0.64 0.62

Siemens Healthineers AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.61 0.62 0.61 0.61

Siemens Healthineers AG COGS-to-Revenue Calculation

Siemens Healthineers AG's COGS to Revenue for the fiscal year that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=13895 / 22363
=0.62

Siemens Healthineers AG's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3586 / 5909
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siemens Healthineers AG  (WBO:SHL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Siemens Healthineers AG's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3586 / 5909
=39.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Siemens Healthineers AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG Business Description

Address
Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines